LHC — Q1 2022 Earnings Presentation
25 slides from LHC's earnings presentation, May 4, 2022
Slide 1: Supplemental Financial Information First Quarter Ended March 31, 2022
SUPPLEMENTAL FINANCIAL INFORMATION First Quarter Ended March 31, 2022 May 4, 2022 Exhibit 99.2
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company, or the timing or anticipated benefits of pending acquisitio
Slide 3: Table of Contents
TABLE OF CONTENTS BUSINESS OVERVIEW 4-9 LHC Group Overview Commentary on Q4 2021 Home Health Labor Cost per Visit Industry-Leading Quality and Patient Satisfaction 3 2022 CONSOLIDATED RESULTS 10-14 2022 Adjusted Consolidated Results Adjusted Consolidated Results – 2022 vs 2021 Adjustments to Net Inc
Slide 4: Business Overview
BUSINESS OVERVIEW
Slide 5: LHC Group Overview
Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC GROUP OVERVIEW LEGEND: 546 home health locations 169 hospice locations 135 home & community based services locations 12 long term acute care hospital locations 106 other service locations 435 leading h
Slide 6: Commentary on Q1 2022
Adjusted net income attributable to LHC Group’s common stockholders was $33.4 million, or $1.09 adjusted earnings per diluted share in Q1 2022. Adjusted EBITDA was $54.5 million in Q1 2022. Higher labor costs and capacity constraints caused by the lingering impact of clinicians on quarantine caused
Slide 7: Commentary on Q1 2022 continued
Home Health salaries and wages inclusive of sign on bonuses increased 5.1% in Q1 2022 over Q1 2021 but decreased 2.0% sequentially from Q4 2021. Home Health salaries and wages excluding sign on bonuses increased 2.1% in Q1 2022 over Q1 2021 but decreased 3.2% sequentially from Q4 2021. Home Health C
Slide 8: Home Health Labor Cost per Visit
HOME HEALTH LABOR COST PER VISIT 8
Slide 9: Industry-Leading Quality and Patient Satisfaction
INDUSTRY-LEADING QUALITY AND PATIENT SATISFACTION 100% of LHC Group home health and hospice agencies are Joint Commission accredited or are in the accreditation process within 12 to 18 months after acquisition. Approximately 15% of all Medicare certified home health agencies nationwide are Joint Com
Slide 10: 2022 Consolidated Results
2022 CONSOLIDATED RESULTS
Slide 11: 2022 Adjusted Consolidated Results
2022 ADJUSTED CONSOLIDATED RESULTS 11
Slide 12: Adjusted Consolidated Results – 2022 vs 2021
ADJUSTED CONSOLIDATED RESULTS – 2022 VS 2021 12
Slide 13: Adjustments to Net Income
ADJUSTMENTS TO NET INCOME *See footnotes on page 27 13
Slide 14: Adjustments to Net Income Continued
ADJUSTMENTS TO NET INCOME CONTINUED Expenses and other costs associated with recently announced or completed acquisitions, de novos and the pending acquisition by UnitedHealth Group. ($4.1 million pre-tax in the three months ended March 31, 2022). Loss on the sale of an asset and other expenses asso
Slide 15: Segment Results
SEGMENT RESULTS
Slide 16: Three Months Ended March 31, 2022 Adjusted Segment Results
THREE MONTHS ENDED MARCH 31, 2022 ADJUSTED SEGMENT RESULTS 16
Slide 17: Home Health Segment Adjusted Segment Results – 2022 vs 2021
HOME HEALTH SEGMENT ADJUSTED SEGMENT RESULTS – 2022 VS 2021 For the three months ended March 31, 2022, Revenue increased by $16.1 million or 4.3% as compared to Q1 2021. The increase in revenue is due to approximately $14 million of inorganic revenue from the HCA/Brookdale acquisition, along with an
Slide 18: Hospice Segment Adjusted Segment Results – 2022 vs 2021
For the three months ended March 31, 2022, revenue increased $39.4 million. The increase in revenue is due to approximately $38.5 million of inorganic revenue from recent acquisitions and approximately $1 million from same store growth. For the three months ended March 31, 2022, Adjusted Earnings Be
Slide 19: Home and Community Based Services Segment Adjusted Results – 2022 vs 2021
For the three months ended March 31, 2022, revenue decreased $4.8 million compared to Q1 2021. The decrease in revenue is due to a 12.0% decline in billable hours owing to ongoing staffing constraints due to the COVID-19 pandemic partially offset by a 2.5% rate improvement. For the three months ende
Slide 20: Facility-Based Services Segment Adjusted Results – 2022 vs 2021
For the three months ended March 31, 2022, revenue increased by $0.5 million compared to Q1 2021. The increase in revenue is due to approximately $4.1 million of inorganic revenue from the recent acquisition of therapy service providers from Brookdale, offset by a 3.1% decrease in patient days in th
Slide 21: Health Care Innovations Segment Adjusted Results – 2022 vs 2021
21 HEALTH CARE INNOVATIONS SEGMENT ADJUSTED SEGMENT RESULTS – 2022 VS 2021
Slide 22: Appendix
APPENDIX
Slide 23: Non-GAAP Reconciliations (Amounts in Thousands, Unaudited)
NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) *Footnotes are on page 24 23
Slide 24: Non-GAAP Reconciliations: Adjusted EBITDA
NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) Expenses and other costs associated with recently announced or completed acquisitions, de novos and the pending acquisition by UnitedHealth Group. ($4.
Slide 25: LHC Group - It's all about helping people
LH Cc GROUP It’s all about helping people.